ePrivacy and GPDR Cookie Consent by TermsFeed Generator

XOLAIR

150MG INJ PSO LQF 4+4X2ML AMP

SÚKL code 0026128
Name of the product XOLAIR
_MA_MEDICATION_DETAIL_INFO_MED_NAME i XOLAIR
Supplement 150MG INJ PSO LQF 4+4X2ML AMP
Strenght 150MG
Pharmaceutical form Powder and solvent for solution for injection
Package 4+4X2ML AMP
Route Subcutaneous use
Wrap type Vial
Legal status na lékařský předpis
Active substance OMALIZUMAB (OMALIZUMABUM)
ATC group R03DX05
ATC group name OMALIZUMAB

Marketing authorisation information

Registration Number EU/1/05/319/003
Type of MA centralised without orphans
MA status R - active MA/authorised medicinal product
MA Holder Novartis Europharm Limited, Dublin
MA Holder country IRSKO

Back to list